Anticancer effects of garlic and garlic-derived bioactive compounds and its potential status as functional food

Jacky Zong, Danik M. Martirosyan


Background: Garlic or Allium savitum has long been used to treat various diseases, including cancer. The anticancer effects of garlic are linked to several garlic-derived organosulfur compounds, including allicin, ajoene, DAS, DADS, DATS, and SAMC. Animal and in vitro studies have demonstrated that garlic bioactive compounds may prevent cancer through mechanisms such as inducing cell cycle arrest, promoting apoptosis, and inhibiting angiogenesis in different cancer cells. Observational studies, including case-control and cohort studies, have been conducted to confirm the protective effect against colorectal, gastric, and other cancers associated with garlic-derived bioactive compounds and raw garlic consumption. However, the results of these studies are mixed. We analyzed cell and animal studies in addition to epidemiological studies using the FDA’s evidence-based review system for health claims and FFC’s proposed standard for evaluating and developing functional food. Through our analysis, we concluded garlic is not a functional food due to the inconclusive data from observational studies and insufficient evidence from randomized clinical trials.


Keywords: Garlic, cancer, allicin, bioactive compound, functional food

Full Text: [Abstract] [Full Article]

DOI: 10.31989/bchd.v1i2.530


  • There are currently no refbacks.

Copyright (c) 2018 Jacky Zong, Danik M. Martirosyan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.